On July 30, 2012 the Board of Directors of Human Stem Cells Institute Open Joint-Stock Company elected Aleksandr Prikhodko as Chairman of the Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.54 RUB | +1.43% |
|
-.--% | -.--% |
26/04 | Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.06Cr | |
+19.32% | 8.35TCr | |
-21.99% | 7.54TCr | |
+2.32% | 2.67TCr | |
-5.06% | 1.82TCr | |
+6.95% | 1.81TCr | |
+7.69% | 1.65TCr | |
+76.20% | 1.41TCr | |
+76.56% | 1.3TCr | |
-27.89% | 1.27TCr |
- Stock Market
- Equities
- ISKJ Stock
- News Human Stem Cells Institute
- Human Stem Cells Institute Open Joint-Stock Company Elects Aleksandr Prikhodko as Chairman of the Board